A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
Clinical trial NCT07677267 · RECRUITING
Trial details
- NCT number
- NCT07677267
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-30
- Primary completion
- 2026-11-30
- Enrollment
- 1067
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.